Since Aβ is derived from the cleavage of amyloid precursor protein (APP) by beta-site APP-cleaving enzyme 1 (BACE1) and the β-secretase complex [94], targeting APP has the potential to delay AD progress. This evidence concerns the gene BACE1 and Alzheimer disease.